These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 22998292)
1. Metabolic and toxicological considerations for sepsis drug treatments. Campbell SC; Spigarelli MG; Courter J; Sherwin CM Expert Opin Drug Metab Toxicol; 2013 Jan; 9(1):79-89. PubMed ID: 22998292 [TBL] [Abstract][Full Text] [Related]
2. Novel approaches to the development of anti-sepsis drugs. Lehmann C; Sharawi N; Al-Banna N; Corbett N; Kuethe JW; Caldwell CC Expert Opin Drug Discov; 2014 May; 9(5):523-31. PubMed ID: 24697209 [TBL] [Abstract][Full Text] [Related]
3. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
4. Metabolic, toxicological, and safety considerations for drugs used to treat ADHD. Duong S; Chung K; Wigal SB Expert Opin Drug Metab Toxicol; 2012 May; 8(5):543-52. PubMed ID: 22413882 [TBL] [Abstract][Full Text] [Related]
5. The safety profile of moxifloxacin and other fluoroquinolones in special patient populations. Iannini PB Curr Med Res Opin; 2007 Jun; 23(6):1403-13. PubMed ID: 17559736 [TBL] [Abstract][Full Text] [Related]
6. The staging of sepsis: understanding heterogeneity in treatment efficacy. Marshall JC Crit Care; 2005; 9(6):626-8. PubMed ID: 16356249 [TBL] [Abstract][Full Text] [Related]
7. Detection and management of nephrotoxicity during drug development. Loghman-Adham M; Kiu Weber CI; Ciorciaro C; Mann J; Meier M Expert Opin Drug Saf; 2012 Jul; 11(4):581-96. PubMed ID: 22616935 [TBL] [Abstract][Full Text] [Related]
8. Metabolic and toxicological considerations of botanicals in anticancer therapy. Fimognari C; Ferruzzi L; Turrini E; Carulli G; Lenzi M; Hrelia P; Cantelli-Forti G Expert Opin Drug Metab Toxicol; 2012 Jul; 8(7):819-32. PubMed ID: 22540949 [TBL] [Abstract][Full Text] [Related]
9. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials. EFSA GMO Panel Working Group on Animal Feeding Trials Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408 [TBL] [Abstract][Full Text] [Related]
10. Metabolic and toxicological considerations for diuretic therapy in patients with acute heart failure. Aspromonte N; Cruz DN; Valle R; Bonello M; Tubaro M; Gambaro G; Marchese G; Santini M; Ronco C Expert Opin Drug Metab Toxicol; 2011 Sep; 7(9):1049-63. PubMed ID: 21599566 [TBL] [Abstract][Full Text] [Related]
11. [C-reactive protein concentrations during initial (empiric) treatment of neonatal sepsis]. Janković B; Pasić S; Marković M; Veljković D; Milicić M Srp Arh Celok Lek; 2001; 129 Suppl 1():17-22. PubMed ID: 15637985 [TBL] [Abstract][Full Text] [Related]
12. The efficacy and toxicity of two dosing-regimens of amikacin in neonates with sepsis. Abdel-Hady E; El Hamamsy M; Hedaya M; Awad H J Clin Pharm Ther; 2011 Feb; 36(1):45-52. PubMed ID: 21198719 [TBL] [Abstract][Full Text] [Related]
13. Renal supportive therapy for pediatric acute kidney injury in the setting of multiorgan dysfunction syndrome/sepsis. Brophy PD Semin Nephrol; 2008 Sep; 28(5):457-69. PubMed ID: 18790365 [TBL] [Abstract][Full Text] [Related]
14. Advances in the emergency management of pediatric sepsis. Melendez E; Bachur R Curr Opin Pediatr; 2006 Jun; 18(3):245-53. PubMed ID: 16721143 [TBL] [Abstract][Full Text] [Related]
16. The Challenge of Developing New Therapies for Childhood Cancers. Balis FM Oncologist; 1997; 2(1):I-II. PubMed ID: 10388032 [TBL] [Abstract][Full Text] [Related]
17. Antibiotic use in neonatal sepsis. Yurdakök M Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468 [TBL] [Abstract][Full Text] [Related]
18. New ways of insulin delivery. Heinemann L Int J Clin Pract Suppl; 2011 Feb; (170):31-46. PubMed ID: 21323811 [TBL] [Abstract][Full Text] [Related]
19. The efficacy and safety of antibiotic combination therapy for infections caused by Gram-positive and Gram-negative organisms. Hagihara M; Crandon JL; Nicolau DP Expert Opin Drug Saf; 2012 Mar; 11(2):221-33. PubMed ID: 22074343 [TBL] [Abstract][Full Text] [Related]
20. Lessons for the future: a review of sepsis past and present. Kaplan BI; Tipirneni P IDrugs; 2007 Apr; 10(4):264-9. PubMed ID: 17390250 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]